tbuckley/cabot-search huggingface dataset:
Origins and spread of formal ceremonial complexes in the Olmec and Maya regions revealed by airborne lidar
Authors: Takeshi Inomata, Juan Carlos Fernandez-Diaz, Daniela Triadan, Miguel García Mollinedo, Flory Pinzón, Melina García Hernández, Atasta Flores, Ashley Sharpe, Timothy Beach, Gregory W. L. Hodgins, Juan Javier Durón Díaz, Antonio Guerra Luna, Luis Guerrero Chávez, María de Lourdes Hernández Jiménez, Manuel Moreno Díaz
Journal: Nature Human Behaviour (2021)
TCT-205 Real-World Experience With the Cusp-Overlap Deployment Technique in Transcatheter Aortic Valve Replacement for Self-Expandable Valves
Authors: Oliver Maier, Kerstin Piayda, Stephan Binneboessel, Nora Berisha, Shazia Afzal, Amin Polzin, Ralf Westenfeld, Patrick Horn, Christian Jung, Tobias Zeus, Verena Veulemans
Journal: Journal of the American College of Cardiology (2021)
Estimating Recurrence Risk in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer
Authors: Christopher D’Avella, J. Nicholas Bodor
Journal: JAMA Network Open (2021)

Stephanie P. L. Saw, MD; Siqin Zhou, MStat; Jianbin Chen, PhD; Gillianne Lai, MD; Mei-Kim Ang, MD; Kevin Chua, MD; Ravindran Kanesvaran, MD; Quan Sing Ng, MD; Amit Jain, MD; Wan Ling Tan, MD; Tanujaa Rajasekaran, MD; Darren W. T. Lim, MD; Aaron Tan, PhD; Kam Weng Fong, MD; Angela Takano, MD; Xin Ming Cheng, MD; Kiat Hon Lim, MD; Tina Koh, MD; Boon-Hean Ong, MD; Eng Huat Tan, MD; Chee Keong Toh, MD; Anders J. Skanderup, PhD; Sze Huey Tan, PhD; Daniel S. W. Tan, PhD
TCT-72 Primary Versus Secondary Retrograde Approach in Chronic Total Occlusion Interventions
Authors: Spyridon Kostantinis, Khaldoon Alaswad, Dimitri Karmpaliotis, Farouc Amin Jaffer, Wissam Jaber, William Nicholson, Stephane Rinfret, Jaikirshan Khatri, Paul Poommipanit, Judit Karacsonyi, Evangelia Vemmou, Ilias Nikolakopoulos, Vennela Avula, Alessandra Gutierrez, Ioannis Tsiafoutis, Robert Riley, Abdul Sheikh, Mitul Patel, Sevket Gorgulu, Ahmed ElGuindy, Omer Goktekin, Nidal Abi-Rafeh, Bavana Rangan, Santiago Garcia, M. Nicholas Burke, Emmanouil Brilakis
Journal: Journal of the American College of Cardiology (2021)
院内心停止のCPRの日本レジストリー(J-RCPR)からの報告
Authors: Yokoyama Hiroyuki, Yonemoto Naohiro, Yonezawa Kazuya, Fuse Jun, Shimizu Naoki, Hayashi Toshimasa, Tsuji Teppei, Yoshikawa Kei, Wakamatsu Hiroya, Otani Nozomu, Sakuragi Satoru, Fukusaki Masahiko, Tanaka Hideki, Nonogi Hiroshi
Journal: Circulation (2011)
Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice
Authors: Zhicong Zhao, Xia Deng, Jue Jia, Li Zhao, Chenxi Wang, Zhensheng Cai, Chang Guo, Ling Yang, Dong Wang, Suxian Ma, Jialiang Deng, Haoxiang Li, Libin Zhou, Zhigang Tu, Guoyue Yuan
Journal: Metabolism (2021)
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
Authors: Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, Rachel Katz, Esma Herzel, Jacob Kuint, Gabriel Chodick, Sivan Gazit, Tal Patalon, Roy Kishony
Journal: Nature Medicine (2021)

The effectiveness of the coronavirus disease 2019 (COVID-19) BNT162b2 vaccine in preventing disease and reducing viral loads of breakthrough infections (BTIs) has been decreasing, concomitantly with the rise of the Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, it is unclear whether the observed decreased effectiveness of the vaccine in reducing viral loads is inherent to the Delta variant or is dependent on time from immunization. By analyzing viral loads of over 16,000 infections during the current, Delta-variant-dominated pandemic wave in Israel, we found that BTIs in recently fully vaccinated individuals have lower viral loads than infections in unvaccinated individuals. However, this effect starts to decline 2 months after vaccination and ultimately vanishes 6 months or longer after vaccination. Notably, we found that the effect of BNT162b2 on reducing BTI viral loads is restored after a booster dose. These results suggest that BNT162b2 might decrease the infectiousness of BTIs even with the Delta variant, and that, although this protective effect declines with time, it can be restored, at least temporarily, with a third, booster, vaccine dose. Vaccination with BNT162b2 is associated with lower viral load in breakthrough infections of SARS-CoV-2, but this effect wanes at 2 months and vanishes at 6 months after vaccination. A third vaccine dose—or booster—restores the reduction in viral load.
A Review of Transcatheter Treatment of Valvular Heart Disease
Authors: Jonathan D. Katz, Robert J. Suriani
Journal: JAMA (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
3D-printed bioactive ceramic scaffolds with biomimetic micro/nano-HAp surfaces mediated cell fate and promoted bone augmentation of the bone–implant interface in vivo
Authors: Xiao Liu, Yali Miao, Haifeng Liang, Jingjing Diao, Lijing Hao, Zhifeng Shi, Naru Zhao, Yingjun Wang
Journal: Bioactive Materials (2021)

Calcium phosphate bio-ceramics are osteo-conductive, but it remains a challenge to promote the induction of bone augmentation and capillary formation. The surface micro/nano-topography of materials can be recognized by cells and then the cell fate are mediated. Traditional regulation methods of carving surface structures on bio-ceramics employ mineral reagents and organic additives, which might introduce impurity phases and affect the biological results. In a previous study, a facile and novel method was utilized with ultrapure water as the unique reagent for hydrothermal treatment, and a uniform hydroxyapatite (HAp) surface layer was constructed on composite ceramics (β-TCP/CaSiO3) in situ. Further combined with 3D printing technology, biomimetic hierarchical structure scaffolds were fabricated with interconnected porous composite ceramic scaffolds as the architecture and micro/nano-rod hybrid HAp as the surface layer. The obtained HAp surface layer favoured cell adhesion, alleviated the cytotoxicity of precursor scaffolds, and upregulated the cellular differentiation of mBMSCs and gene expression of HUVECs in vitro. In vivo studies showed that capillary formation, bone augmentation and new bone matrix formation were upregulated after the HAp surface layer was obtained, and the results confirmed that the fabricated biomimetic hierarchical structure scaffold could be an effective candidate for bone regeneration.
Nitric oxide controls proliferation of Leishmania major by inhibiting the recruitment of permissive host cells
Authors: Pauline Formaglio, Mohamad Alabdullah, Anastasios Siokis, Juliane Handschuh, Ina Sauerland, Yan Fu, Anna Krone, Patricia Gintschel, Juliane Stettin, Sandrina Heyde, Juliane Mohr, Lars Philipsen, Anja Schröder, Philippe A. Robert, Gang Zhao, Sahamoddin Khailaie, Anne Dudeck, Jessica Bertrand, Gerald F. Späth, Sascha Kahlfuß, Philippe Bousso, Burkhart Schraven, Jochen Huehn, Sebastian Binder, Michael Meyer-Hermann, Andreas J. Müller
Journal: Immunity (2021)

Nitric oxide (NO) is an important antimicrobial effector but also prevents unnecessary tissue damage by shutting down the recruitment of monocyte-derived phagocytes. Intracellular pathogens such as Leishmania major can hijack these cells as a niche for replication. Thus, NO might exert containment by restricting the availability of the cellular niche required for efficient pathogen proliferation. However, such indirect modes of action remain to be established. By combining mathematical modeling with intravital 2-photon biosensors of pathogen viability and proliferation, we show that low L. major proliferation results not from direct NO impact on the pathogen but from reduced availability of proliferation-permissive host cells. Although inhibiting NO production increases recruitment of these cells, and thus pathogen proliferation, blocking cell recruitment uncouples the NO effect from pathogen proliferation. Therefore, NO fulfills two distinct functions for L. major containment: permitting direct killing and restricting the supply of proliferation-permissive host cells.
Blockading a new NSCLC immunosuppressive target by pluripotent autologous tumor vaccines magnifies sequential immunotherapy
Authors: Hong Wu, Hongyan Li, Yiqiang Liu, Jingchen Liang, Qianshi Liu, Zhigang Xu, Zhongzhu Chen, Xia Zhang, Kun Zhang, Chuan Xu
Journal: Bioactive Materials (2021)

The presence of multiple immunosuppressive targets and insufficient activation and infiltration of cytotoxic T lymphocytes (CTLs) allow tumor cells to escape immune surveillance and disable anti-PD-1/PD-L1 immunotherapy. Nanobiotechnology-engineered autologous tumor vaccines (ATVs) that were camouflaged by tumor cell membrane (TCM) were designed to activate and facilitate CTLs infiltration for killing the unprotected lung tumor cells, consequently realizing the sequential immunotherapy. PDE5 was firstly screened out as a new immunosuppressive target of lung cancer in clinical practice. Immediately afterwards, phosphodiesterase-5 (PDE5) and programmed cell death 1 ligand 1 (PD-L1) dual-target co-inhibition was proposed to unfreeze the immunosuppressive microenvironment of NSCLC. Systematic studies validated that this ATVs-unlocked sequential immunotherapy after co-encapsulating PDE5 inhibitor and NO donor (i.e., l-arginine) exerted robust anti-tumor effects through increasing inducible nitric oxide synthase (iNOS) expression, blockading PDE5 pathway and activating systematic immune responses, which synergistically eradicated local and abscopal lung cancers in either orthotopic or subcutaneous models. The pluripotent ATVs that enable PDE5 inhibition and sequential immunotherapy provide a new avenue to mitigate immunosuppressive microenvironment and magnify anti-PD-1/PD-L1 immunotherapy.
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
Authors: Kennedy Yao Yi Ng, Sze Huey Tan, Jack Jie En Tan, Desiree Shu Hui Tay, Ailica Wan Xin Lee, Andrea Jing Shi Ang, Lawrence Wen Jun Wong, Su Pin Choo, David Wai-Meng Tai, Joycelyn Jie Xin Lee
Journal: Liver Cancer (2021)

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; Development of immune-related adverse events (irAEs) has been associated with enhanced efficacy with the use of immune checkpoint inhibitors (ICIs). It remains unknown whether such an association exists in advanced hepatocellular carcinoma (aHCC). This study aims to evaluate the association between irAEs and ICI efficacy in patients with aHCC. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; We performed a retrospective cohort study on patients with aHCC who received at least one dose of an ICI between May 2015 and November 2019 at the National Cancer Centre Singapore. The primary study objectives were to compare the overall survival (OS) and progression-free survival (PFS) between patients with and without irAEs. Complementary multivariable landmark analyses were performed at the 6-week and 12-week landmarks. Data cutoff was December 31, 2020. &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; One hundred and sixty-eight patients were included. Median age was 69 years, 85.7% were male, 57.7% had hepatitis B infection, 60.7% had ECOG 0, and 78.0% had Child-Pugh A liver cirrhosis. 82.7% received ICI monotherapy, while 17.3% received ICI in combination. Development and severity of irAE were correlated with survival. The median PFS for grade ≥3 irAE versus grades 1–2 irAE versus no irAE was 8.5 versus 3.6 versus 1.3 mths (&lt;i&gt;p&lt;/i&gt; &amp;#x3c; 0.001). The median OS for grade ≥3 irAE versus grades 1–2 irAE versus no irAE was 26.9 versus 14.0 versus 4.6 mths (&lt;i&gt;p&lt;/i&gt; &amp;#x3c; 0.001). Patients with ≥2 irAEs had a significantly longer OS on multivariable analysis (adjusted hazard ratio [aHR]0.35, &lt;i&gt;p&lt;/i&gt; &amp;#x3c; 0.001). The presence of grade ≥3 irAEs was associated with a significantly longer OS on the multivariable analysis at the 6-week landmark (aHR0.34, &lt;i&gt;p&lt;/i&gt; = 0.030) and 12-week landmark (aHR0.28, &lt;i&gt;p&lt;/i&gt; = 0.011). The use of systemic corticosteroids in patients with irAE was associated with a trend toward a longer OS (20.7 vs. 14.3 mths, &lt;i&gt;p&lt;/i&gt; = 0.064). &lt;b&gt;&lt;i&gt;Conclusion:&lt;/i&gt;&lt;/b&gt; Our study suggests that the presence of all-grade irAEs may be a potential prognostic biomarker in patients with aHCC treated with ICI. Patients with more severe irAEs and multisystem involvement have better prognosis. The prompt use of systemic corticosteroids to treat patients with irAEs is key to ensure the best long-term outcomes for these patients.
TCT-460 Mobility Aids Predict Mortality After Transcatheter Aortic Valve Replacement
Authors: Sandeep Arunothayaraj, Reshma Amin, David Kirtchuk, Timothy Williams, Kristoffer Vincent Tanseco, Michael Michail, James Cockburn, Uday Trivedi, David Hildick-Smith
Journal: Journal of the American College of Cardiology (2021)
Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer’s disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies
Authors: Tao Song, Xiaopeng Song, Chenyawen Zhu, Regan Patrick, Miranda Skurla, Isabella Santangelo, Morgan Green, David Harper, Boyu Ren, Brent P. Forester, Dost Öngür, Fei Du
Journal: Ageing Research Reviews (2021)
TCT-399 Relationship Between Coronary CT Angiography–Derived Fractional Flow Reserve and Clinical Outcomes in Patients With and Without Diabetes
Authors: Gaurav Gulsin, Georgios Tzimas, Hidenobu Takagi, Rachel Eddy, Philipp Blanke, Park Park, Lynne Koweek, Bjarne Norgaard, Mark Rabbat, Tmothy Fairbairn, Kavitha Chinnaiyan, Pamela Douglas, Whitney Huey, Hitoshi Matsuo, Niels Peter Rønnow Sand, Koen Nieman, Jeroen Bax, Tetsuya Amano, Tomohiro Kawasaki, Takashi Akasaka, Campbell Rogers, Daniel Berman, Manesh Patel, Bernard De Bruyne, Sarah Mullen, Jonathon Leipsic
Journal: Journal of the American College of Cardiology (2021)
Integration and functional performance of a decellularised porcine superflexor tendon graft in an ovine model of anterior cruciate ligament reconstruction
Authors: Jennifer Helen Edwards, Gemma Louise Jones, Anthony Herbert, John Fisher, Eileen Ingham
Journal: Biomaterials (2021)

The objective was to evaluate the performance of decellularised porcine superflexor tendon (pSFT) as an anterior cruciate ligament (ACL) reconstruction device. The ACL of adult sheep was reconstructed with decellularised pSFT or ovine allograft SFT and animals sacrificed at 4, 12 and 26 weeks (n = 4 per group) for biological evaluation and 26 weeks (n = 6) for biomechanical evaluation of the grafts. Both grafts showed good in vivo performance with no major differences at macroscopic evaluation post euthanasia. Histopathology revealed an inflammatory reaction to both grafts at 4 weeks, which reduced by 26 weeks. There was advanced cellular ingrowth from 12 weeks, ligamentisation of intra-articular grafts, ossification and formation of Sharpey's fibers at the graft/bone junctions. Immunohistochemistry showed that at 4 and 12 weeks, the host response was dominated by CD163+ M2 macrophages and a cell infiltrate comprising α-SMA + myofibroblasts, CD34
TCT-103 Safety and Effectiveness of Transcatheter Edge-to-Edge Repair With MitraClip in Atrial Functional MR: An Analysis of the Global EXPAND Study
Authors: Nishtha Sodhi, Aniela Petrescu, Ralph Stephan von Bardeleben, Scott Lim, Federico Asch, Francesco Maisano, Saibal Kar, Matthew Price
Journal: Journal of the American College of Cardiology (2021)
Mechanism of activation and the rewired network: New drug design concepts
Authors: Ruth Nussinov, Mingzhen Zhang, Ryan Maloney, Chung‐Jung Tsai, Bengi Ruken Yavuz, Nurcan Tuncbag, Hyunbum Jang
Journal: Medicinal Research Reviews (2021)

Abstract Precision oncology benefits from effective early phase drug discovery decisions. Recently, drugging inactive protein conformations has shown impressive successes, raising the cardinal questions of which targets can profit and what are the principles of the active/inactive protein pharmacology . Cancer driver mutations have been established to mimic the protein activation mechanism. We suggest that the decision whether to target an inactive (or active) conformation should largely rest on the protein mechanism of activation. We next discuss the recent identification of double (multiple) same‐allele driver mutations and their impact on cell proliferation and suggest that like single driver mutations, double drivers also mimic the mechanism of activation. We further suggest that the structural perturbations of double (multiple) in cis mutations may reveal new surfaces/pockets for drug design. Finally, we underscore the preeminent role of the cellular network which is deregulated in cancer. Our structure‐based review and outlook updates the traditional Mechanism of Action, informs decisions, and calls attention to the intrinsic activation mechanism of the target protein and the rewired tumor‐specific network, ushering innovative considerations in precision medicine.
Multi-organ graft-versus-host disease after nivolumab for relapsed Hodgkin lymphoma: the role of plasma exchange
Authors: Rodothea Amerikanou, Lorna Neill, Manar Shafat, Harriet Roddy, Harpreet Hyare, Sian Hughes, Kirsty Thomson, Karl S Peggs, Arian Laurence, Maeve O'Reilly, Claire Roddie
Journal: The Lancet Haematology (2021)
Cake Decorating Luster Dust Associated with Toxic Metal Poisonings — Rhode Island and Missouri, 2018–2019
Authors: Brendalee Viveiros, Genevieve Caron, Jonathan Barkley, Evan Philo, Sharon Odom, Jeff Wenzel, Mark Buxton, Elizabeth Semkiw, Alan Schaffer, Laura Brown, Adrienne S. Ettinger
Journal: MMWR Morbidity and Mortality Weekly Report (2021)

During 2018-2019, the Rhode Island Department of Health (RIDOH) and the Missouri Department of Health and Senior Services (DHSS) investigated cases of metal poisonings associated with commercially and home-prepared cakes decorated with products referred to as luster dust. Several types of glitters and dusts, broadly known as luster dust,* for use on prepared foods can be purchased online and in craft and bakery supply stores (1). Decorating foods with luster dust and similar products is a current trend, popularized on television programs, instructional videos, blogs, and in magazine articles.† Some luster dusts are specifically produced with edible ingredients that can be safely consumed. Companies that make edible luster dust are required by law to include a list of ingredients on the label (2). Luster dusts that are safe for consumption are typically marked "edible" on the label. Some luster dusts used as cake decorations are not edible or food grade; labeled as "nontoxic" or "for decorative purposes only," these luster dusts are intended to be removed before consumption (3). RIDOH (2018) and Missouri DHSS (2019), investigated heavy metal poisonings associated with commercially and home-prepared cakes decorated with luster dust after receiving reports of children (aged 1-11 years) who became ill after consuming birthday cake. Cases in Rhode Island were associated with copper ingestion, and the case in Missouri was associated with a child's elevated blood lead level. In Rhode Island, luster dust products that had been used in cake frosting were found to contain high levels of multiple metals.§ These events indicate that increased vigilance by public health departments and further guidance to consumers and bakeries are needed to prevent unintentional poisonings. Labeling indicating that a product is nontoxic does not imply that the product is safe for consumption. Explicit labeling indicating that nonedible products are not safe for human consumption is needed to prevent illness from inappropriate use of inedible products on foods. Educating consumers, commercial bakers, and public health professionals about potential hazards of items used in food preparation is essential to preventing illness and unintentional poisoning from toxic metals and other nonedible ingredients.
From Copenhagen to Nyborg 2022: take the Tour de France Route to #WCSPT2022
Authors: Lars Damsbo, Karen Kotila, Julie Sandell Jacobsen, Lisbeth Lund Pedersen, Charlotte Anker-Petersen, Michael Skovdal Rathleff, Thomas Bandholm, Kristian Thorborg
Journal: British Journal of Sports Medicine (2021)

It is finally time to meet again in person. Danish Society of Sports Physical Therapy (DSSF) is busy organising #Sportskongres2022 in Copenhagen (3 February 2022–5 February 2022) and #WCSPT2022 in Nyborg (26 August 2022–27 August 2022). As the front cover of this BJSM issue illustrates, you can take the 2022 Tour de France Route from the venue of #Sportskongres2022 (https://www.sportskongres.dk/) in Copenhagen, city of the first stage of Tour de France (https://letourcph.dk/en) to the finish line of the second stage in Nyborg, the city that will host #WCSPT2022 (www.wcspt.org). You will cross the beautiful Great Belt over the second longest suspension bridge in the world. The symbolism is clear, sports PT and Sports medicine will reunite and meet in person in 2022.

WCSPT is a collaboration between IFSPT and a national member organisation—this time DSSF. It is our goal for #WCSPT2022 to make room for discussion and reflection on how to apply new knowledge into a clinical setting. The overarching theme is ‘Translating science into Practice’. …
TCT-290 Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus: Results From the PIONEER III Clinical Trial
Authors: Alexander Thomas, Dean Kereiakes, Martin Leon, Andreas Baumbach, Stephan Windecker, Cody Pietras, Ovidiu Dressler, Melek Issever, Michael Curtis, Barry Bertolet, James Zidar, Pieter Smits, Victor Alfonso Jimenez Diaz, Brent Mclaurin, Angel Cequier, Akihiko Takahashi, Giovanni Amoroso, Tsunekazu Kakuta, Robert Carney, Shigeru Saito, Alexandra Lansky
Journal: Journal of the American College of Cardiology (2021)
Author Correction: Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin
Authors: Jung Seok Lee, Patrick Han, Rabib Chaudhury, Shihan Khan, Sean Bickerton, Michael D. McHugh, Hyun Bong Park, Alyssa L. Siefert, Gerald Rea, José M. Carballido, David A. Horwitz, Jason Criscione, Karlo Perica, Robert Samstein, Ragy Ragheb, Dongin Kim, Tarek M. Fahmy
Journal: Nature Biomedical Engineering (2021)